Avenir Corporation’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$945K Hold
36,745
0.12% 44
2026
Q1
$756K Hold
36,745
0.09% 45
2025
Q4
$871K Hold
36,745
0.09% 44
2025
Q3
$915K Hold
36,745
0.1% 42
2025
Q2
$845K Hold
36,745
0.09% 44
2025
Q1
$825K Hold
36,745
0.09% 41
2024
Q4
$718K Hold
36,745
0.07% 44
2024
Q3
$669K Hold
36,745
0.07% 44
2024
Q2
$639K Hold
36,745
0.06% 45
2024
Q1
$720K Hold
36,745
0.06% 41
2023
Q4
$846K Buy
36,745
+7,100
+24% +$159K 0.07% 39
2023
Q3
$682K Hold
29,645
0.06% 41
2023
Q2
$774K Sell
29,645
-200
-0.7% -$5.28K 0.07% 41
2023
Q1
$824K Sell
29,845
-16
-0.1% -$422 0.08% 40
2022
Q4
$678K Buy
29,861
+12,361
+71% +$344K 0.07% 41
2022
Q3
$596K Hold
17,500
0.06% 44
2022
Q2
$510K Hold
17,500
0.05% 46
2022
Q1
$468K Hold
17,500
0.04% 49
2021
Q4
$453K Buy
+17,500
New +$436K 0.03% 52

Other funds holding PRVA

Avenir Corporation's PRVA Position: Q2 2026 in Review

Avenir Corporation held its Privia Health (PRVA) position steady in Q2 2026 at 36,745 shares worth $945K. The position accounts for 0.12% of the portfolio, ranked #44.

Avenir Corporation first reported a position in PRVA in Q4 2021 and has held it in 19 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Avenir Corporation held 36,745 shares of Privia Health worth $945K as of Q2 2026.
  • Avenir Corporation left its Privia Health share count unchanged in Q2 2026.
  • Privia Health made up 0.12% of Avenir Corporation's portfolio in Q2 2026, its #44 holding.
  • Avenir Corporation first reported a position in Privia Health in Q4 2021 and has held it in 19 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Avenir Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.